Ionis Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2023
Total Assets: $2.99B
Liabilities Breakdown FY2023
Total Liabilities: $2.60B
Asset Breakdown
Total Assets: $2.99B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $399.3M | 13.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $7.4M | 0.2% |
| Property, Plant & Equipment | $71.0M | 2.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.51B | 84.0% |
Liabilities Breakdown
Total Liabilities: $2.60B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $26.0M | 1.0% |
| Long-Term Debt | $1.24B | 47.7% |
| Other Liabilities | $1.34B | 51.3% |